PATENT CLAIM ANALYSIS

Application Number: 16003861
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["544", "090000"]

Abstract:
The present invention is directed to compounds of Formula I: and pharmaceutically acceptable salts, prodrugs, solvates, hydrates, tautomers, or isomers or thereof, wherein R 1 , R 2 , R 2 ′, L, X, W, Y 1 , Y 2 , Y 3 , and Y 4  are described herein.

Claim (Index 105):
The composition of  claim 97 , wherein the composition comprises: or a pharmaceutically acceptable salt thereof, wherein the compound is obtained by a process, comprising the step of treating the compound: with hydroxylamine and a first base to form the compound:

Metadata:
- Claim Count in Document: 3.0
- Percentile: 94.0
- Lexical Diversity: 1.63158
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15255817', '15925559', '15013820', '15130603', '15130613']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7903802893760326
- 35 USC 102 Novelty (BERT): 0.5204646151076971
- Combined Prediction Score: 0.763388721949199
- Mean Citation Score: 304.46262800000005
- Max Citation Score: 340.1715700000001
- Similarity Product: 228.91173645596032

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test